In the published article, there was an error in 2 Materials and methods, 2.10 Clinical Case, paragraph 1. This work includes a SPECT scan of a human patient, which was said to have received approval from the institutional ethics committee. However, the project’s protocol number does not correspond to the indicated patient. This sentence previously stated:
“The study received approval from the institutional ethics committee (CAAE: 66235122.0.0000.0071).”
The corrected sentence appears below:
“The pilot study received approval from the institutional ethics committee and the patient signed the corresponding informed consent to use the SPECT images for research purposes.”
Consequently, there was also an error in the Ethics statement. The original statement was as follows:
“The animal study was approved by Ethics Committee on Animal Use of the Hospital Israelita Albert Einstein (protocol #4005/19). The study was conducted in accordance with the local legislation and institutional requirements. The human study was approved by the Ethics Committee of the Hospital Israelita Albert Einstein (CAAE: 66235122.0.0000.0071) and informed consent was obtained from all individual participants included in this study.”
The corrected statement appears below:
“The animal study was approved by Ethics Committee on Animal Use of the Hospital Israelita Albert Einstein (protocol #4005/19). The study was conducted in accordance with the local legislation and institutional requirements. The pilot human study was approved by the Ethics Committee of the Hospital Israelita Albert Einstein and informed consent was obtained from the participant included in this study.”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
PSMA-I&S, technetium-99m, cold kits for radiopharmaceuticals, SPECT imaging, radioguided surgery, prostate cancer
Citation
Fuscaldi LL, Sobral DV, Durante AC, Mendonça FF, Miranda ACC, Salgueiro C, de Castiglia SG, Yamaga LYI, da Cunha ML, Malavolta L, de Barboza MF and Mejia J (2024) Corrigendum: Radiochemical and biological assessments of a PSMA-I&S cold kit for fast and inexpensive 99mTc-labeling for SPECT imaging and radioguided surgery in prostate cancer. Front. Chem. 12:1539768. doi: 10.3389/fchem.2024.1539768
Received
04 December 2024
Accepted
06 December 2024
Published
24 December 2024
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2024
Updates
Copyright
© 2024 Fuscaldi, Sobral, Durante, Mendonça, Miranda, Salgueiro, de Castiglia, Yamaga, da Cunha, Malavolta, de Barboza and Mejia.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Leonardo Lima Fuscaldi, leonardo.fuscaldi@hotmail.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.